Olink Flex
Access new customizable panels
Combine 5-30 protein biomarkers into a single panel, without compromising on data quality. Available now.
A significant milestone in proteomics research
The number of peer-reviewed scientific articles citing Olink now exceeds 2,000, revealing interesting recent trends in protein biomarker research.
What is a good biomarker?
Register for this informative webinar to understand the critical role of protein biomarkers in advancing personalized medicine and improving clinical trial outcomes.
Olink Target 48
New Immune Surveillance panel now available. Perform immune biomarker profiling with absolute confidence.
Olink Insight
Journey from experiment planning and study design to post-run data analysis – in a single online bioinformatic app.
Landmark articles in Nature show the power of population-scale proteogenomics
Publications
Read the latest impressive findings from the UK Biobank Pharma Proteomics Project.
Empowering genomics with high-throughput proteomics
E-book
Explore recent advancements in our pioneering field. Discover how top scientists use high-throughput proteomics to advance precision medicine.
One platform. Endless possibilities.
PEA Technology
Meet the next-generation proteomics platform trusted by small lab teams and leading pharma companies.
Latest news
Stay updated with the latest Olink news, including press releases, events, and notable publications describing cutting-edge research and key advancements in proteomics.
Blog
UK Biobank Population-level Studies Using Olink’s PEA Technology Advance Disease Understanding and Therapy Development
Explore the transformative potential of integrating proteomics with genomics. Dr. Ryan Dhindsa’s research with UK Biobank data using Olink’s PEA technology identifies thousands of rare genotype-protein associations, revealing new disease-associated genes and therapeutic targets.
Press release
Olink Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease
Olink announces the availability of an open-access data library consisting of over 300,000 protein-disease risk associations, giving researchers a powerful new tool for revealing the biological mechanisms underlying 106 human diseases.